Eph receptor B2 (EphB2), an important member of the Eph receptor family, has been demonstrated to be aberrantly expressed in many cancer types, including colorectal cancer, gastric cancer, and HCC, where it results in tumor occurrence and progression [114]. This evidence concerns the gene EPHB2 and gastric cancer.